Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 HKD | +1.42% | +2.52% | -14.93% |
06-25 | Jinxin Fertility Group Limited Approves Final Dividend for the Year Ended December 31, 2023 | CI |
03-29 | Jinxin Fertility Logs 185% Profit Surge in 2023 as Revenue Rises 18% | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.93% | 1.01B | B- | ||
+18.33% | 83.89B | C+ | ||
-28.29% | 71.08B | B- | ||
+0.99% | 26.77B | C+ | ||
+3.67% | 17.74B | A- | ||
-9.99% | 17.24B | B | ||
+1.86% | 15.6B | A- | ||
+79.98% | 13.84B | C- | ||
-25.09% | 12.92B | - | - | |
+74.41% | 12.87B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 1951 Stock
- Ratings Jinxin Fertility Group Limited